Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- FAScinate Therapeutics Inc.
- Target Recruit Count
- 314
- Registration Number
- NCT05670782
- Locations
- 🇺🇸
Parexel Early Phase Clinical Unit, Glendale, California, United States
🇺🇸University California San Diego Medical Center, San Diego, California, United States
🇺🇸Quest Research Institute, Rose Cancer Center, Royal Oak, Michigan, United States
News
No news found